Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

Cardiologist became paralyzed after wearing heavy aprons in the cath lab for decades—but he fought back
Dean J. Kereiakes, MD, was left paralyzed after battling severe orthopedic issues for his entire career. Back in the cath lab after a long recovery, he is now stressing the importance of workplace safety among interventional cardiologists.
Heart patients benefit when cardiologists follow a standardized TAVR protocol
Using a standardized approach, including the cusp overlap technique, is associated with improved patient outcomes when implanting Medtronic's self-expanding TAVR valves. Researchers tracked data from more than 600 patients treated all over the world, presenting their findings in JSCAI.
SCAI celebrates legacies of pioneer pediatric cardiologists
Five veteran clinicians have been recognized for their lasting impact on the field of pediatric cardiology.
SCAI wants lead-free cath labs and a better work-life balance for cardiologists
"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview.
Robotic PCI confirmed to be both safe and effective in new comprehensive analysis
Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.

Dean Kereiakes, a nationally renowned interventional cardiologist and president of The Christ Hospital Heart and Vascular Institute, has long been recognized for his groundbreaking work in cardiovascular research and intervention. But in 2024, his career and his life were permanently altered when decades of wearing heavy lead protection in the cath lab left him paralyzed.

Cardiologist became paralyzed after wearing heavy aprons in the cath lab for decades—but he fought back

Dean J. Kereiakes, MD, was left paralyzed after battling severe orthopedic issues for his entire career. Back in the cath lab after a long recovery, he is now stressing the importance of workplace safety among interventional cardiologists.

Newsweek ranked the 50 best heart hospitals in the world

Heart patients benefit when cardiologists follow a standardized TAVR protocol

Using a standardized approach, including the cusp overlap technique, is associated with improved patient outcomes when implanting Medtronic's self-expanding TAVR valves. Researchers tracked data from more than 600 patients treated all over the world, presenting their findings in JSCAI.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

SCAI celebrates legacies of pioneer pediatric cardiologists

Five veteran clinicians have been recognized for their lasting impact on the field of pediatric cardiology.

Video interview with Hari Naidu SCAI president on the need for policy for increased radiation protection in the cath lab.

SCAI wants lead-free cath labs and a better work-life balance for cardiologists

"The lead protection we wear is causing a lot of damage," SCAI President Srihari S. Naidu, MD, a veteran interventional cardiologist, explained in an interview.

Robotic PCI confirmed to be both safe and effective in new comprehensive analysis

Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.

Stenting ‘an important treatment option’ for PCI patients with complete blockages

The study's lead author emphasized that stenting during CTO PCI procedures "should be considered safe and effective in the long term."

tirzepatide injections Zepbound Eli Lilly

Tirzepatide bests semaglutide in patients with type 2 diabetes, kidney disease and heart failure

Researchers examined data from more than 9,000 patients, sharing their findings at SCAI 2025.

Srihari S. Naidu, MD, FACC, FAHA, MSCAI, assumed the role of president of the Society for Cardiovascular Angiography and Interventions (SCAI) May 3 during the society's annual meeting. He outlined his ambitious plans to take SCAI in some new directions. #SCAI #SCAI2025

New SCAI president lists advocacy, cardiogenic shock among his top priorities

Srihari Naidu, MD, spoke to Cardiovascular Business about his plan to take SCAI in some bold new directions.

Around the web

Health Exec

Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging

Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.